ArTS Archivio della ricerca di Trieste

MARCUZZI, ANNALISA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.483
EU - Europa 4.021
AS - Asia 727
AF - Africa 30
Continente sconosciuto - Info sul continente non disponibili 13
SA - Sud America 11
OC - Oceania 1
Totale 11.286
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.471
PL - Polonia 2.426
SE - Svezia 483
CN - Cina 325
UA - Ucraina 308
IT - Italia 304
HK - Hong Kong 223
FI - Finlandia 112
DE - Germania 90
TR - Turchia 84
BG - Bulgaria 76
IE - Irlanda 71
VN - Vietnam 37
FR - Francia 35
GB - Regno Unito 35
BE - Belgio 27
SN - Senegal 26
SG - Singapore 23
CH - Svizzera 13
KR - Corea 13
CA - Canada 11
NL - Olanda 11
EU - Europa 9
IN - India 8
ES - Italia 7
RO - Romania 7
A2 - ???statistics.table.value.countryCode.A2??? 4
AT - Austria 4
BR - Brasile 4
CL - Cile 3
DK - Danimarca 3
IL - Israele 3
NG - Nigeria 3
HR - Croazia 2
JP - Giappone 2
PT - Portogallo 2
VE - Venezuela 2
AL - Albania 1
BD - Bangladesh 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
FK - Isole Falkland (Malvinas) 1
GR - Grecia 1
HU - Ungheria 1
ID - Indonesia 1
IQ - Iraq 1
IR - Iran 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MX - Messico 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
Totale 11.286
Salva come PNG Salva come JPEG
Città #
Warsaw 2.425
Fairfield 899
Woodbridge 840
Houston 669
Ann Arbor 625
Chandler 506
Ashburn 503
Seattle 429
Wilmington 406
Jacksonville 298
Cambridge 294
Hong Kong 221
Princeton 136
Trieste 108
Dearborn 83
Beijing 78
Sofia 76
Izmir 72
Dublin 71
Boardman 38
Dong Ket 36
San Diego 36
Falls Church 35
Dakar 26
Grafing 26
Brussels 25
Jinan 23
Helsinki 22
Des Moines 21
Hefei 20
Phoenix 20
Kunming 18
Washington 18
Nanjing 17
Shanghai 17
Hebei 15
Redwood City 15
Seoul 11
Bremen 10
Columbus 10
Milan 10
Chicago 9
Nanchang 9
Fuzhou 8
Kocaeli 8
Toronto 8
Fremont 7
Guangzhou 7
Shenyang 7
Bern 6
Changsha 6
Chengdu 6
Edinburgh 6
Taizhou 6
Venezia 6
New York 5
Singapore 5
Zhengzhou 5
Amsterdam 4
Andover 4
Berlin 4
Bologna 4
Brescia 4
Dallas 4
Haikou 4
Norwalk 4
Pune 4
Tappahannock 4
Tianjin 4
Brøndby 3
Buffalo 3
Centro 3
Chongqing 3
Detroit 3
Dongguan 3
Düsseldorf 3
Fort Worth 3
Gorizia 3
Lagos 3
Leawood 3
London 3
Los Angeles 3
Mumbai 3
Nürnberg 3
Perugia 3
Rome 3
Silea 3
São Paulo 3
Taiyuan 3
Zurich 3
Augusta 2
Caracas 2
Chaoyang 2
Edmonton 2
Groningen 2
Karlsruhe 2
Lipari 2
Lisbon 2
Madrid 2
Mestre 2
Totale 9.449
Salva come PNG Salva come JPEG
Nome #
Ex vivo response to mucosal bacteria and muramyl dipeptide in inflammatory bowel disease 356
Geranylgeraniol and Neurological Impairment: Involvement of Apoptosis and Mitochondrial Morphology 335
To extinguish the fire from outside the cell or to shutdown the gas valve inside? Novel trends in anti-inflammatory therapies 334
Alendronate, a double-edged sword acting in the mevalonate pathway 332
Neuronal Dysfunction Associated with Cholesterol Deregulation. 322
Innovative Target Therapies Are Able to Block the Inflammation Associated with Dysfunction of the Cholesterol Biosynthesis Pathway. 306
Inflammatory bowel disease and patterns of volatile organic compounds in the exhaled breath of children: A case-control study using Ion Molecule Reaction-Mass Spectrometry 306
Curcumin anti-apoptotic action in a model of intestinal epithelial inflammatory damage 295
Type i interferon-mediated autoinflammation due to DNase II deficiency 290
Two‑gene mutation in a single patient: Biochemical and functional analysis for a correct interpretation of exome results. 289
Pediatric patients with inflammatory bowel disease exhibit increased serum levels of proinflammatory cytokines and chemokines, but decreased circulating levels of macrophage inhibitory protein-1β, interleukin-2 and interleukin-17 284
The complex interplay between lipids, immune system and interleukins in cardio-metabolic diseases 259
Repositioning Of Tak-475 In Mevalonate Kinase Disease: Translating Theory Into Practice 258
Monocyte-predominant engraftment, cytokine levels and early transplant-related complications in pediatric hematopoietic stem cell recipients 242
Clinical Genetic Testing of Periodic Fever Syndromes 226
Is autophagy an elective strategy to protect neurons from dysregulated cholesterol metabolism? 215
The farnesyltransferase inhibitors tipifarnib and lonafarnib inhibit cytokines secretion in a cellular model of mevalonate kinase deficiency. 209
Antibodies reacting to mimotopes of Simian virus 40 large T antigen, the viral oncoprotein, in sera from children. 186
Natural isoprenoids inhibit LPS-induced-production of cytokines and nitric oxide in aminobisphosphonate-treated monocytes. 182
Comments on ''Geranylgeraniol--a new potential therapeutic approach to bisphosphonate associated osteonecrosis of the jaw" by Ziebart T et al. (2011). 179
Microglia activation and interaction with neuronal cells in a biochemical model of mevalonate kinase deficiency 177
A comparative analysis of serologic parameters and oxidative stress in osteoarthritis and rheumatoid arthritis: reply to Mishra and colleagues 172
Decreased cholesterol levels reflect a consumption of anti-inflammatory isoprenoids associated with an impaired control of inflammation in a mouse model of mevalonate kinase deficiency. 171
A common genetic background could explain early-onset Crohn's disease. 171
Targeting farnesyl-transferase as a novel therapeutic strategy for mevalonate kinase deficiency: In vitro and in vivo approaches. 170
Defect in mevalonate pathway induces pyroptosis in Raw 264.7 murine monocytes. 170
Letter to the editor: acute effects of intravenous administration of pamidronate in patients with osteoporosis. 170
Comments to the editor concerning the paper entitled "Preclinical renal cancer chemopreventive efficacy of geraniol by modulation of multiple molecular pathways" Shiekh Tanveer Ahmad et al. 168
Inflammation profile of four early onset Crohn patients. 165
Database tools in genetic diseases research. 162
Cytokine profiles of women with vulvodynia: Identification of a panel of pro-inflammatory molecular targets 161
Long non-coding RNA gas5 and intestinal mmp2 and mmp9 expression: A translational study in pediatric patients with IBD 156
Mevalonate kinase deficiency and IBD: shared genetic background 155
Altered germinal center reaction and abnormal B cell peripheral maturation in PI3KR1-mutated patients presenting with HIGM-like phenotype 154
Evolutionary hypothesis of the Mevalonate Kinase Deficiency. 151
Cytokine levels in the serum of healthy subjects. 151
Block of the Mevalonate Pathway Triggers Oxidative and Inflammatory Molecular Mechanisms Modulated by Exogenous Isoprenoid Compounds 148
Farnesyl and geranylgeranyl transferase inhibitors: an anti-inflammatory effect. Comment to "Inhibition of protein geranylgeranylation and farnesylation protects against graft-versus-host disease via effects on CD4 effector T cells" Haematologica. 2013;98(1):31-40 147
Lovastatin dose-dependently potentiates the pro-inflammatory activity of lipopolysaccharide both in vitro and in vivo 145
Curcumin and inflammatory bowel disease: Potential andlimits of innovative treatments 141
Natural isoprenoids are able to reduce inflammation in a mouse model of mevalonate kinase deficiency. 140
Lovastatin induces apoptosis through the mitochondrial pathway in an undifferentiated SH-SY5Y neuroblastoma cell line 132
Putative modifier genes in mevalonate kinase deficiency 132
Letter: inflammatory bowel disease, complementary and alternative medicine, and genetics 131
null 130
Family history in early-onset inflammatory bowel disease 127
Serum amyloid A and cholesterol: a pivotal role on inflammation. 127
Mevalonate Kinase Deficiency and Neuroinflammation: Balance between Apoptosis and Pyroptosis 126
Specific protein profile in cerebrospinal fluid from HIV-1-positive cART-treated patients affected by neurological disorders. 118
Temperature and Drug Treatments in Mevalonate Kinase Deficiency: An Ex Vivo Study 111
null 109
null 108
Mevalonate kinase deficiency: therapeutic targets, treatments, and outcomes 108
Microcapsule a doppio strato di polisaccaridiutilizzabili come veicoli per la somministrazione oraledi sostanze biologicamente attive 107
Presence of IL-9 in paired samples of human colostrum and transitional milk. 106
Autoinflammatory syndromes and coeliac disease: One observation and two hypotheses 106
Mevalonate kinase deficiency: disclosing the role of mevalonate pathway modulation in inflammation. 96
Geraniol rescues inflammation in cellular and animal models of mevalonate kinase deficiency 88
Clarification of the pleiotropic effects of statins on mevalonate pathway and the feedback regulation of isoprenoids requires more comprehensive investigation. 88
null 86
New Mechanisms in Autoinflammatory Diseases 83
TRAIL administration down-modulated the acute systemic inflammatory response induced in a mouse model by muramyldipeptide or lipopolysaccharide. 76
The Challenge of Next Generation Sequencing in a Boy with Severe Mononucleosis and EBV-related Lymphoma 74
Mouse model of mevalonate kinase deficiency: comparison of cytokines and chemokines profile with human patients 67
MIF plasma level as a possible tool to predict steroid responsiveness in children with idiopathic nephrotic syndrome 63
Role of vitamin D in the pathogenesis of atheromatosis 61
Lovastatin-induced apoptosis is modulated by geranylgeraniol in a neuroblastoma cell line. 56
Standard treatment–refractory cytomegalovirus encephalitis unmasked by immune reconstitution inflammatory syndrome and successfully treated with virus-specific hyperimmune globulin 50
The effect of clodronate on a mevalonate kinase deficiency cellular model. 40
Post-Irradiation Hyperamylasemia Is a Prognostic Marker for Allogeneic Hematopoietic Stem Cell Transplantation Outcomes in Pediatric Population: A Retrospective Single-Centre Cohort Analysis 30
New Applications of JAK/STAT Inhibitors in Pediatrics: Current Use of Ruxolitinib 29
Systemic and neuronal inflammatory markers in a mouse model of mevalonate kinase deficiency: a strain-comparative study. 25
Mevalonate kinase deficiency and squalene synthase inhibitor (TAK-475): The balance to extinguish the inflammation 25
Defibrotide impact on the acute GVHD disease incidence in pediatric hematopoietic stem cell transplant recipients 21
Lysozyme-containing chitosan-coated arginate microspheres for oral immunisation 11
Totale 11.597
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.351
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.351
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019736 0 0 0 0 0 0 0 0 0 0 453 283
2019/20203.087 191 176 178 490 216 432 376 290 270 152 199 117
2020/20211.820 173 150 150 186 185 185 166 127 118 190 67 123
2021/2022974 48 50 56 59 78 102 58 18 98 91 77 239
2022/20231.384 164 201 118 206 117 246 1 109 145 10 56 11
2023/2024713 33 57 56 54 81 99 160 148 14 9 2 0
Totale 11.597